2026 NPPES data Gynecologic Oncology Physician NPI 1558569830 MD
Verify on CMS →

MEHDI MOSLEMI-KEBRIA, MD

Gynecologic Oncology Physician in UPLAND, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
183
Medicare Part D claims · 99 beneficiaries · Gynecologic Oncology Physician avg: 188
Generic prescribing
79%
generic claims · 21% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
99.1275/100
▲ 16 pts above national avg 83.1 · [object Object]
Industry payments
$30.8K
18 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MEHDI MOSLEMI-KEBRIA, MD is a Gynecologic Oncology Physician ([object Object]) practicing in UPLAND, California with a Medicare Part D prescribing footprint of 183 claims across 99 beneficiaries — 21% brand-name prescribing . Their CMS MIPS Final Score of 99.1275/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $30.8K across 18 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MEHDI MOSLEMI-KEBRIA, MD reported a CMS MIPS final score of 99.1275 out of 100, above the 83.1 national average, and filed 183 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MEHDI MOSLEMI-KEBRIA, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MEHDI MOSLEMI-KEBRIA, MD at a glance

High performer (top quartile)

NPI registry status

Active

Issued 07/06/2007

NPI 1558569830

Primary specialty

Gynecologic Oncology Physician

Niche

1,360 US NPIs in this specialty

Medicare Part D claims

183 3% vs specialty avg

2023 prescription claims

Specialty avg: 188

MIPS final score

99.1275/100 16.027500000000003% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in California

How Gynecologic Oncology Physician compares to other specialties among California providers

California providers

Gynecologic Oncology Physician share within California

1. Gynecologic Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Gynecologic Oncology Physician share within California

Medicare quality performance — MIPS

MEHDI MOSLEMI-KEBRIA, MD's 2023 MIPS final score plotted against the Gynecologic Oncology Physician national average

High performer (top quartile)
MIPS Final Score
99.1275/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Gynecologic Oncology Physician) — 99.1275/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Gynecologic Oncology Physician) — 99.1275/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MEHDI MOSLEMI-KEBRIA, MD is a Gynecologic Oncology Physician provider practicing in UPLAND, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1558569830. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MEHDI MOSLEMI-KEBRIA, MD appears in the CMS NPPES registry as a Gynecologic Oncology Physician provider holding MD credentials at 1100 SAN BERNARDINO ROAD, UPLAND, CA, 91786, with a listed phone of (909) 949-2242. NPI 1558569830 was issued on 07/06/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MOSLEMI-KEBRIA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 183 prescription claims written by this provider, covering 99 Medicare beneficiaries and totaling roughly $7K in drug spend, split 21% brand-name and 79% generic by claim count, with an opioid prescribing rate of 15.3%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 99.1275/100 for the 2023 performance year (Quality 85.2396), compared with the national average of 83.1.

Gynecologic Oncology Physician is a narrow specialty nationwide, with 1,360 enrolled providers across 49 states and an average of 188 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1100 SAN BERNARDINO ROAD
UPLAND, CA 91786

Provider Details

NPI 1558569830
Specialty Gynecologic Oncology Physician
Credentials MD
Gender Male
NPI Issued 07/06/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

99.1275
Final Score
Avg: 83.1
85.2396
Quality
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where MEHDI MOSLEMI-KEBRIA, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

CITY OF HOPE MEDICAL FOUNDATION
IRVINE, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MEHDI MOSLEMI-KEBRIA, MD. Source: openpaymentsdata.cms.gov.

Total received

$30.8K

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to MEHDI MOSLEMI-KEBRIA, MD. To verify MEHDI MOSLEMI-KEBRIA, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

MEHDI MOSLEMI-KEBRIA, MD — brand share 21.0%
Specialty average (est.)

21% brand-name claims vs 79% generic, on 183 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

183
Total Claims
$7K
Total Drug Cost
99
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
188
Total Day Supply
1,531
Brand vs Generic
21% brand / 79% generic
Brand Drug Cost
$3K
Generic Drug Cost
$3K
Opioid Claims
28 (15.3% rate)
Antibiotic Claims
61

Patient Demographics

Average Patient Age
71.1 years
Avg HCC Risk Score
1.44
Gender Split
100% female / 0% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Levofloxacin
51
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
15
Ibuprofen
14
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
12
Sod Sulf-Potass Sulf-Mag Sulf
"Sodium
N/A

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Gynecologic Oncology Physician Overview

How MEHDI MOSLEMI-KEBRIA, MD fits within the Gynecologic Oncology Physician landscape nationally.

1,360
Gynecologic Oncology Physician Providers in US
49
States with Gynecologic Oncology Physician
188
Avg Claims per Provider

MEHDI MOSLEMI-KEBRIA, MD's 183 claims are below the specialty average of 188.

Nearby Gynecologic Oncology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as MOSLEMI-KEBRIA.

Compare Gynecologic Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MEHDI MOSLEMI-KEBRIA, MD's specialty?
MEHDI MOSLEMI-KEBRIA, MD specializes in Gynecologic Oncology Physician and practices in UPLAND, California. Credentials: MD.
How much does MEHDI MOSLEMI-KEBRIA, MD prescribe under Medicare Part D?
In 2023, MEHDI MOSLEMI-KEBRIA, MD wrote 183 Medicare Part D claims totaling $7K in drug costs for 99 beneficiaries.
What is MEHDI MOSLEMI-KEBRIA, MD's Medicare quality score?
MEHDI MOSLEMI-KEBRIA, MD has a CMS MIPS Final Score of 99.1275/100 (Quality: 85.2396). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MEHDI MOSLEMI-KEBRIA, MD located?
MEHDI MOSLEMI-KEBRIA, MD is located at 1100 SAN BERNARDINO ROAD, UPLAND, CA, 91786. Phone: (909) 949-2242.
What is MEHDI MOSLEMI-KEBRIA, MD's NPI number?
MEHDI MOSLEMI-KEBRIA, MD's National Provider Identifier (NPI) is 1558569830, issued on 07/06/2007.
Does MEHDI MOSLEMI-KEBRIA, MD prescribe more brand-name or generic drugs?
MEHDI MOSLEMI-KEBRIA, MD's prescribing is 21% brand-name and 79% generic drugs by claim count, with $3K in brand drug costs.
Does MEHDI MOSLEMI-KEBRIA, MD prescribe opioids?
Yes, MEHDI MOSLEMI-KEBRIA, MD had 28 opioid claims in 2023 with an opioid prescribing rate of 15.3%.
How many Gynecologic Oncology Physician providers are there in the US?
There are 1,360 Gynecologic Oncology Physician providers across 49 states in the US. The average Gynecologic Oncology Physician provider writes 188 Medicare Part D claims per year.
What drugs does MEHDI MOSLEMI-KEBRIA, MD prescribe most often?
Based on 2023 Medicare Part D data, MEHDI MOSLEMI-KEBRIA, MD's most frequently prescribed drugs include Levofloxacin, Hydrocodone-Acetaminophen, Ibuprofen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MEHDI MOSLEMI-KEBRIA, MD accept Medicare?
MEHDI MOSLEMI-KEBRIA, MD appears in CMS Medicare data with 183 Part D claims and 99 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MEHDI MOSLEMI-KEBRIA, MD's credentials?
MEHDI MOSLEMI-KEBRIA, MD's NPI is 1558569830 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology